Here are 10 health systems and hospitals that posted job listings seeking supply chain expertise in the last week. 

The FDA is transitioning back to traditional regulatory processes to sign off on new COVID-19 tests after clearing more than 430 for emergency use during the pandemic, the agency said Sept. 27.

Prescott's, a surgical microscopes repair company, acquired Preventive Maintenance Medical on Sept. 28, marking its second acquisition since Aug. 22. 

Becton, Dickinson and Co. opened an innovation center and its first university-housed research location on the University of Maryland's BioPark campus in Baltimore Sept. 27. 

A Department of Health and Human Services report found single-use medical devices account for most of hospital greenhouse gas emissions and lead to supply chain disruptions.

Atlanta-based diagnostics company CorDx opened a new facility focused on manufacturing medical supplies with 33,600 square feet of warehouse, manufacturing and assembly areas.

Here are four drug and medical device recalls the FDA reported in September: 

After some pharmacies and hospitals reported running out of Moderna's omicron-targeted booster, the FDA authorized five lots of the product made at the drugmaker's Bloomington, Ind., facility, which isn't authorized to manufacture the modified vaccine. 

With COVID-19 vaccine-makers pivoting production as the virus mutates, Jim Cafone, Pfizer's senior vice president of global supply chain, said it is time for pharmaceutical companies to redevelop their logistic strategies, The Wall Street Journal reported Sept. 24.

In a recent white paper from Becker’s Supply Chain Leadership Virtual Forum, titled “Health system leaders weigh in on supply chain transformation,” 6 healthcare supply chain leaders representing Cardinal Health, Mayo Clinic, UChicago Medicine and other healthcare institutions discussed how supply chains can become a strategic asset when bolstered by the power of data, standardization, and process efficiency.

Workforce shortages and managing supply chain disruptions as the COVID-19 pandemic eases in severity are top of mind for hospital supply leaders. 

Reauthorizing the FDA's user fee program, which allows the agency to decide how much to charge pharmaceutical and medical device-maker companies for their product submissions,  was added to a spending bill Sept. 22 to prevent a government shutdown, according to The Hill.

The FDA is loosening requirements surrounding the distribution of naloxone to increase Americans' access to the opioid overdose antidote.

Here are 10 health systems and hospitals that posted job listings seeking supply chain expertise in the last week. 

From an unusual number of submissions of low-quality COVID-19 tests to limits at U.S. laboratories, the FDA faced multiple barriers in the early days of the COVID-19 pandemic, an HHS report found. 

From a potential cybersecurity risk for some insulin pumps to health equity issues with pulse oximeters, here are four medical device updates the FDA has published as of Sept. 15: 

Drug and medical devicemakers with operations in Puerto Rico are cautiously optimistic that Hurricane Fiona will cause few ripples across the medical supply chain.

When health systems and public health departments were scrambling to respond to the COVID-19 pandemic in early 2020, New York bought ventilators and X-ray machines for more than a quarter of a billion dollars. The products were never used and are sitting in storage, according to a Sept. 20 Politico report. 

Pharmacies and hospitals across the country are running out of Moderna's tweaked vaccine booster, but the vaccine-maker said it expects supply to return to normal levels in a few days. 

Houston-based Texas Medical Center on Sept. 20 unveiled plans to build a biomanufacturing center called the TMC BioPort. It will focus on manufacturing and distributing medical supplies, therapies and pharmaceuticals.